Charles Bessant's smoking cessation after psilocybin

Charles Bessant’s smoking cessation after psilocybin is presented not as a simple story of resisting a craving, but as a change in what mattered to him. During a Johns Hopkins University pilot study, an experience of ego dissolution and awe widened his sense of perspective; afterward, smoking seemed too small to compete with the life and connectedness he had come to value. Bessant, a museum exhibit designer in his sixties, had remained abstinent for six years when the account was written.

The study and its limits

Bessant took part in a smoking-cessation study directed by Matthew Johnson at Johns Hopkins University. The open-label pilot enrolled fifteen volunteer smokers who were trying to quit. Participants first received several sessions of cognitive behavioral therapy, followed by two or three psilocybin sessions. There was no placebo group, and participants knew they would receive the drug. They had to stop smoking before a psilocybin session; researchers measured carbon-monoxide levels at several intervals to check compliance and confirm continued abstinence.

That design matters to the meaning of Bessant’s account. It documents a striking individual experience within a structured treatment program, but it does not isolate psilocybin’s effect from the therapy, participants’ expectations, or the attention given to them. His six years of abstinence is a concrete outcome reported in the book, not proof that the drug alone caused it. The study’s small size and open-label format leave the broader effectiveness of the approach unresolved.

The book places this uncertainty against an older dispute over LSD treatment for alcohol dependence. By the end of the 1950s, LSD was widely regarded in North America as a promising treatment, and the Saskatchewan provincial government helped make it a standard option in the province. In the early 1960s, the Addiction Research Foundation in Toronto tried to replicate those results under more controlled conditions. Volunteers were placed in neutral rooms, instructed not to engage with clinicians except to complete questionnaires, and sometimes constrained or blindfolded. Those conditions produced worse results and frightening experiences for some participants. The contrast suggested that the therapeutic environment and human engagement could matter alongside the drug. Bessant’s study was not the same experiment, but this history cautions against treating a psychedelic session as a drug acting in isolation.

The experience that changed smoking’s scale

Bessant described his psilocybin experience as taking place on a mountaintop in the Alps, with the German states stretching before him to the Baltic and Wagner playing in his headphones. His ego had dissolved, he said, but he could still recount what had happened; the experience was terrifying as well as expansive. He connected it to the language of unity and belonging: “People use words like ‘oneness,’ ‘connectivity,’ ‘unity’—I get it! I was part of something so much larger than anything I had ever imagined.”

The decisive consequence was not a detailed argument against tobacco. In Bessant’s telling, the experience altered the relative importance of smoking. He explained that the immensity of what he had encountered made the habit seem pitifully small: “Why quit smoking? Because I found it irrelevant. Because other things had become so much more important.” The shift is the center of his account. Smoking did not become the subject of an extended struggle in the narrative; it lost its place in the scale of concerns by which he understood his life.

Awe in ordinary surroundings

Bessant’s description did not remain confined to the extraordinary landscape of his session. In a later conversation, he paused to describe standing in his garden as light came through the canopy of leaves. He attributed to the session a renewed capacity to notice and value that scene, saying that seeing it depended on his eyes being open and that it was a gift to feel amazement at the light. He summarized the change as “a feeling of connectedness to everything.”

This movement from a visionary mountaintop to a garden gives his account a particular shape: the experience’s importance lies not only in its scale, but in what it made perceptible afterward. The book compares this shift to an overview effect on a person’s own life, a vantage from which problems that once felt daunting can seem smaller and more manageable. Bessant’s reported change fits that comparison: his new perspective did not erase the fact of smoking, but changed its place among the things he considered worth attending to.

He continued to search for language adequate to the experience, following up the conversation by email with clarifications and elaborations. Yet the explanation he offered for quitting was strikingly plain: smoking had become irrelevant. The gap between the immensity of his account and the simplicity of that conclusion is part of its force. He did not claim that a single insight settled the scientific question of treatment efficacy; he described how, in his own case, a shift in perspective coincided with sustained abstinence.